Novartis Investigative Site

Svidník, Slovakia 089 01

0 studies enrolling now · 2 studies all time

What they study most

Heart Failure, Moderate to Severe Plaque-type Psoriasis

Studies at this site

• A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure — Stopped early
• Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens — Completed